Meet your 2022 Faculty for the Master Class On Demand Learning
Track Directors
Harold J. Burstein MD, PhD
Medical Oncologist
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Jean M. Connors MD
Medical Director, Anticoagulation Management Service
Brigham and Women’s Hospital
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Bruce E. Johnson MD
Chief Clinical Research Officer
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Faculty
Janet L. Abrahm, MD
Medical Oncologist
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Thomas A. Abrams, MD
Senior Physician
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Kenneth C. Anderson, MD
Program Director
Jerome Lipper Multiple Myeloma Center and LeBow Institute
for Myeloma Therapeutics
Dana-Farber Cancer Institute
Kraft Family Professor of Medicine
Harvard Medical School
Sharon L. Bober, PhD
Senior Psychologist
Dana-Farber Cancer Institute
Assistant Professor of Psychiatry
Harvard Medical School
Jennifer A. Chan, MD, MPH
Clinical Director, Gastrointestinal Cancer Center
Director, Program in Carcinoid and Neuroendocrine Tumors
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Matthew S. Davids MD, MMSC
Director
Center for Chronic Lymphocytic Leukemia
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Daniel J. DeAngelo, MD, PhD
Chief, Division of Leukemia
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
George D. Demetri, MD
Director, Sarcoma Center
Senior Vice President for Experimental Therapeutics
Quick Family Chair in Medical Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Robert Dreicer, MD
Professor of Medicine and Urology
University of Virginia School of Medicine
Associate Director for Clinical Research and the Deputy Director
University of Virginia Cancer Center
Section Head of Medical Oncology and Co-Director
Paul Mellon Urologic Institute.
Peter C. Enzinger, MD
Director, Center for Esophageal and Gastric Cancer
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Robert I. Haddad, MD
McGraw Chair in Head and Neck in Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
F. Stephen Hodi, MD
Director, Melanoma Center
Director, Center for Immuno-Oncology
Sharon Crowley Martin Chari in Melanoma
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Ann S. LaCasce MD, MMSC
Director, Fellowship Program (Hematology-Medical Oncology)
Dana-Farber/Massachusetts General Brigham
Associate Professor of Medicine
Harvard Medical School
Nancy U. Lin MD
Associate Chief, Division of Breast Oncology, Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Joyce F. Liu, MD, MPH
Associate Chief, Division of Gynecologic Oncology
Director of Clinical Research, Division of Gynecologic Oncology
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School
Ursula A. Matulonis, MD
Chief, Division of Gynecologic Oncology
Susan F. Smith Center for Women’s Cancers
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Mary Ellen Taplin, MD
Chair, Executive Committee for Clinical Research
Chair of Clinical Research, Lank Center for Genitourinary Oncology
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Ayalew Tefferi, MD
Professor of Medicine and Hematology
Mayo Medical School
Alexis A. Thompson MD, MPH
Chief, Division of Hematology
Elias Schwartz MD Endowed Chair in Hematology
Children’s Hospital of Philadelphia
Matthew B. Yurgelun, MD
Director, Lynch Syndrome Center
Dana-Farber Cancer Institute
Assistant Professor of Medicine
Harvard Medical School